The current findings of the study provide experimental evidence of treadmill running as an effective and non-pharmacologic strategy to treat the susceptibility of brain D2R deficiency to HFD-induced obesity and metabolic disorders. The gene discussed is DRD2; the disease is obesity due to melanocortin 4 receptor deficiency.